Clinical Trial Details
EORTC-55961
Back to Clinical Trials Database
EORTC 55961,Phase II study on Paclitaxel in recurrent uterine papillary serous carcinoma (UPSC)
Trial Status | All trial activities ended |
---|---|
Dates |
Date of activation: 07-Jun-2001 Date Step1 close: 30-Oct-2002 |
Data management at EORTC | Yes |
Design |
Phase 2 Randomized open label |
Targeted Sample size | EORTC Groups: 29 |
Treatment | |
Study Staff | |
Type of cancer | |
Participating groups | |
Protocol summary | http://clinicaltrials.gov/study/NCT00022620 |
NCT number | NCT00022620 |